Cases from the Community: Investigators Provide Their Perspectives on the Practice Implications of Emerging Clinical Research — A Special Video Supplement


Case discussion: A 67-year-old man with ER-positive, HER2-positive, node-positive IDC who has difficulty tolerating adjuvant tamoxifen
3:10 minutes.

Adjuvant and neoadjuvant therapy for HER2-positive breast cancer (BC)

Management of HER2-positive metastatic BC (mBC)

Clinical decision-making for patients with ER-positive early BC

Management of ER-positive, HER2-negative mBC

Indications for BRCA testing in BC and ongoing investigation of PARP inhibition

Treatment of triple-negative BC (TNBC)